Nishkama Capital LLC bought a new stake in Confluent, Inc. (NASDAQ:CFLT - Free Report) in the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 123,418 shares of the company's stock, valued at approximately $2,893,000.
Other hedge funds have also added to or reduced their stakes in the company. ProShare Advisors LLC lifted its position in shares of Confluent by 3.1% during the 4th quarter. ProShare Advisors LLC now owns 10,774 shares of the company's stock worth $301,000 after buying an additional 328 shares in the last quarter. Amalgamated Bank lifted its position in shares of Confluent by 3.4% during the 1st quarter. Amalgamated Bank now owns 16,995 shares of the company's stock worth $398,000 after buying an additional 566 shares in the last quarter. GAMMA Investing LLC lifted its position in shares of Confluent by 26.8% during the 1st quarter. GAMMA Investing LLC now owns 3,128 shares of the company's stock worth $73,000 after buying an additional 661 shares in the last quarter. Jasper Ridge Partners L.P. raised its holdings in shares of Confluent by 4.8% in the 4th quarter. Jasper Ridge Partners L.P. now owns 14,409 shares of the company's stock worth $403,000 after purchasing an additional 664 shares during the period. Finally, M&T Bank Corp raised its holdings in shares of Confluent by 4.4% in the 1st quarter. M&T Bank Corp now owns 22,496 shares of the company's stock worth $527,000 after purchasing an additional 956 shares during the period. Institutional investors and hedge funds own 78.09% of the company's stock.
Insiders Place Their Bets
In other Confluent news, CEO Edward Jay Kreps sold 37,707 shares of the firm's stock in a transaction dated Wednesday, August 20th. The shares were sold at an average price of $17.04, for a total value of $642,527.28. Following the completion of the sale, the chief executive officer directly owned 377,074 shares in the company, valued at $6,425,340.96. This trade represents a 9.09% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Lara Caimi sold 2,864 shares of the firm's stock in a transaction dated Wednesday, June 11th. The stock was sold at an average price of $24.10, for a total transaction of $69,022.40. Following the completion of the sale, the director owned 4,296 shares of the company's stock, valued at $103,533.60. This trade represents a 40.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 627,117 shares of company stock valued at $13,017,274 over the last ninety days. 13.82% of the stock is owned by corporate insiders.
Wall Street Analyst Weigh In
A number of research analysts recently weighed in on the stock. Royal Bank Of Canada reduced their price objective on shares of Confluent from $28.00 to $25.00 and set an "outperform" rating for the company in a research note on Thursday, July 31st. Barclays reduced their price objective on shares of Confluent from $31.00 to $24.00 and set an "overweight" rating for the company in a research note on Friday, August 1st. UBS Group reduced their price objective on shares of Confluent from $32.00 to $28.00 and set a "buy" rating for the company in a research note on Thursday, July 31st. Robert W. Baird reduced their price objective on shares of Confluent from $37.00 to $24.00 and set a "neutral" rating for the company in a research note on Thursday, May 1st. Finally, Needham & Company LLC reduced their price objective on shares of Confluent from $26.00 to $24.00 and set a "buy" rating for the company in a research note on Thursday, July 31st. Two investment analysts have rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, ten have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $27.36.
Check Out Our Latest Research Report on CFLT
Confluent Stock Performance
Shares of NASDAQ:CFLT opened at $17.79 on Monday. The company has a market cap of $6.13 billion, a price-to-earnings ratio of -18.93 and a beta of 0.96. The company has a 50-day moving average price of $22.44 and a 200-day moving average price of $24.12. The company has a current ratio of 3.98, a quick ratio of 3.98 and a debt-to-equity ratio of 1.03. Confluent, Inc. has a 12 month low of $15.64 and a 12 month high of $37.90.
Confluent (NASDAQ:CFLT - Get Free Report) last issued its quarterly earnings data on Wednesday, July 30th. The company reported $0.09 EPS for the quarter, beating the consensus estimate of $0.08 by $0.01. Confluent had a negative net margin of 29.27% and a negative return on equity of 27.34%. The firm had revenue of $282.29 million during the quarter, compared to the consensus estimate of $278.32 million. During the same period in the prior year, the firm posted $0.06 earnings per share. The company's quarterly revenue was up 20.1% compared to the same quarter last year. Confluent has set its Q3 2025 guidance at 0.090-0.100 EPS. FY 2025 guidance at 0.360-0.360 EPS. As a group, equities analysts anticipate that Confluent, Inc. will post -0.83 EPS for the current year.
About Confluent
(
Free Report)
Confluent, Inc operates a data streaming platform in the United States and internationally. The company provides platforms that allow customers to connect their applications, systems, and data layers, such as Confluent Cloud, a managed cloud-native software-as-a-service; and Confluent Platform, an enterprise-grade self-managed software.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Confluent, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Confluent wasn't on the list.
While Confluent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.